ISO-NTCP customisation of the prescription dose in lung-tumour radiotherapy

ISO-NTCP customisation of the prescription dose in lung-tumour radiotherapy

Bibliographic Details
Main Authors:	Malik, Z, Eswar, C, Dobson, J, Fenwick, J, Nahum, A
Format:	Conference item
Published:	2007

Similar Items

Dose-individualisation for lung cancer radiotherapy - are we ready?
by: Malik, Z, et al.
Published: (2007)

Biomathematical model-based analysis of a standard UK dose and fractionation lung tumour radiotherapy protocol
by: Malik, Z, et al.
Published: (2007)

Impact of dose-distribution uncertainties on rectal ntcp modeling. I: Uncertainty estimates.
by: Fenwick, J, et al.
Published: (2001)

Influence of dose calculation algorithms on isotoxic dose-escalation of non-small cell lung cancer radiotherapy.
by: Panettieri, V, et al.
Published: (2010)

Impact of dose-distribution uncertainties on rectal ntcp modeling. II: Uncertainty implications.
by: Fenwick, J
Published: (2001)

The I-START trial: ISoToxic Accelerated RadioTherapy in locally advanced non-small cell lung cancer
by: Lester, J, et al.
Published: (2012)

Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.
by: Fenwick, J, et al.
Published: (2009)

Early mucosal reactions during and after head-and-neck radiotherapy: dependence of treatment tolerance on radiation dose and schedule duration.
by: Fenwick, J, et al.
Published: (2008)

An ntcp formula for the series model with a Yaes-type functional subunit mechanism.
by: Fenwick, J
Published: (2001)

Dose prescription complexity versus tumor control probability in biologically conformal radiotherapy.
by: South, C, et al.
Published: (2009)

On-treatment image-guided radiotherapy for central lung tumours
by: Bendall, L
Published: (2019)

Numerical Study of Effects of Bladder Filling on Prostate Positioning In Radiotherapy
by: Krywonos, J, et al.
Published: (2009)

Delay differential equations and the dose-time dependence of early radiotherapy reactions.
by: Fenwick, J
Published: (2006)

Impact of schedule duration on head and neck radiotherapy: accelerated tumor repopulation versus compensatory mucosal proliferation.
by: Fenwick, J, et al.
Published: (2012)

Impact of schedule duration on head and neck radiotherapy: Accelerated tumor repopulation versus compensatory mucosal proliferation
by: Fenwick, J, et al.
Published: (2012)

Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015
by: Aznar, M, et al.
Published: (2018)

Post-Mastectomy Radiotherapy Involving Supraclavical Nodes – Matchline Dose, Tumour Dose And Organs At Risk Dose
by: Alzoubi, Ahmad Saleem Salem
Published: (2009)

UK proposal for three parallel dose escalation studies in radiotherapy (RT) for Stage I-III non-small cell lung cancer (NSCLQC)-DEAL-RT
by: Hughes, S, et al.
Published: (2007)

Estimation of radiation dose to the lung in patient underoing radiotherapy for breast cancer /
by: 193305 Nuraini Muhammad, et al.
Published: (2004)

Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer.
by: Fenwick, J, et al.
Published: (2001)

Car customising/
by: 422191 Cockburn, Paul
Published: (1970)

18F-FLT PET/CT Sequential Imaging to Quantify Tumour Proliferation During Radiotherapy in Patients With Lung and Head and Neck Cancer
by: Chalkidou, A, et al.
Published: (2011)

18F-FLT PET/CT sequential imaging to quantify tumour proliferation during radiotherapy in patients with lung and head and neck cancer.
by: Chalkidou, A, et al.
Published: (2011)

Using a Monte Carlo model to predict dosimetric properties of small radiotherapy photon fields.
by: Scott, A, et al.
Published: (2008)

Monte Carlo dose calculations and radiobiological modelling: analysis of the effect of the statistical noise of the dose distribution on the probability of tumour control.
by: Buffa, F, et al.
Published: (2000)

Safety and tumour hypoxia modifying effect of buparlisib with radiotherapy in NSCLC: a phase I dose escalation study
by: Skwarski, M, et al.
Published: (2018)

The compromises and flexibility of TEI customisation
by: Cummings, J
Published: (2014)

Dose verification procedures in radiotherapy
by: Zakaria, Ahmad, et al.
Published: (1999)

Normal tissue doses during isotoxically dose escalated lung radiation therapy using MR-linacs
by: Bendall, L, et al.
Published: (2018)

Improved Outcomes With Dose Escalated Hypofractionated Radiotherapy for Prostate Cancer
by: Mackenzie, J, et al.
Published: (2011)

Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.
by: Warren, S, et al.
Published: (2014)

Dose and fractionation in radiotherapy of curative intent for non-small-cell lung cancer: Meta-analysis of randomized trials
by: Rankin, J, et al.
Published: (2016)

Competitive advantage with mass customisation
by: Yap, Siew Eng.
Published: (2008)

Radiotherapy dose-fractionations and outcomes in cancer patients
by: Ramroth, J
Published: (2017)

Computer calculation of dose distributions in radiotherapy
by: 7924 International Atomic Energy Agency
Published: (1966)

Beam analysis and dose measurement in radiotherapy /
by: 175795 Mohd. Adam Saufi Yahya, et al.
Published: (2003)

An experiment validation of treatment plannning system dose calculation accuracy in heterogeneous lung tumour
by: Lee, Wen Han
Published: (2022)

Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma
by: McGowan, D, et al.
Published: (2019)

Estimating the risks of breast cancer radiotherapy: Evidence from modern radiation doses to the lungs and heart and from previous randomised trials
by: Taylor, C, et al.
Published: (2017)

Isotoxic dose escalation with real-time imaging on an MR-linac in lung radiation therapy
by: Bendall, L, et al.
Published: (2018)